Investors in Agricultural

Managing over €1 billion in assets, Trigon Capital Group is a holding company dedicated to driving growth across a diverse range of industries all linked together by a common purpose of creating a more environmentally sustainable future. Trigon Group has been operating in Central and Eastern Europe for over 30 years since its founding in 1994. We believe this region has exceptional growth potential as it converges with Western Europe and some of the strongest macroeconomic indicators in the world. We see exciting opportunities for our group to expand in the region going forward. Our team leverages both regional and global finance and investment, business development and related experience.

The Agro Innovation Lab is a joint innovation platform of BayWa & RWA, two of the most important players in the global agricultural sector. The Agro Innovation Lab takes an active part in shaping the future of agriculture. Our mission is to foster new technologies or strategies, which increase efficiency, conserve resources or significantly improve the lives of farmers and thus the lives of consumers and customers.

BASF Venture Capital is the corporate venture capital arm of BASF Group. They invest worldwide in promising young enterprises relevant to BASF’s current and future business fields and also in funds. Besides innovations in the fields of chemistry, new materials and sustainability, their areas of focus include digitization and new business models. They support their portfolio companies through selective interactions with the global research, partnership and customer networks of the BASF Group.

Regenerate Ventures is an early-stage investor focused on leading agricultural innovation companies. The firm identifies and supports startups that are pioneering advancements in agriculture, with a particular emphasis on sustainable practices, technologies, and solutions. Regenerate Ventures provides crucial capital, strategic guidance, and industry expertise to help these companies scale their operations and accelerate their impact on the agricultural sector. By investing in innovative agricultural technologies and practices, Regenerate Ventures aims to drive positive environmental outcomes, enhance food security, and promote sustainable farming practices globally. The firm plays a pivotal role in supporting the transition towards a more sustainable and resilient agricultural industry.

RUG Holding is a venture capital firm dedicated to investing in innovative companies within the biotechnology and regulated business sectors. With a strategic focus on fostering advancements in biotech and regulated industries, RUG Holding identifies promising startups and growth-stage enterprises poised for impactful growth and development. The firm provides essential capital, strategic guidance, and operational support to empower portfolio companies in navigating complex regulatory landscapes and accelerating market adoption. By leveraging its expertise and network, RUG Holding aims to drive innovation, facilitate industry leadership, and create sustainable value for its stakeholders. Positioned at the intersection of science, technology, and regulation, RUG Holding plays a crucial role in shaping the future of biotech and regulated markets.

Agileo Ventures is a global investment vehicle focused on supporting tech-driven markets with a strong emphasis on Tech for Good, Green Tech, New Energies, and other technology-centric sectors. The firm aims to identify and invest in innovative companies that are pioneering solutions with positive societal and environmental impacts. Agileo Ventures leverages its agility and global perspective to capitalize on opportunities across emerging and transformative sectors, driving sustainable growth and innovation. By nurturing partnerships with visionary entrepreneurs and supporting groundbreaking technologies, Agileo Ventures contributes to shaping a future where technology plays a pivotal role in addressing global challenges and advancing sustainable development goals.

Sound Bioventures is a Venture Capital firm that Invests in private clinical stage biotherapeutics companies in Europe and USA. The fund has a geographic footprint on both sides of the Atlantic and will support the clinical development of novel medicines for diseases of high unmet medical need.